The iShares Nasdaq Biotechnology (IBB) ETF just hit a new all-time high. It’s up 29% so far this year. The S&P 500 is up just 3%.
This is nothing new… biotech stocks have been killing it for years. IBB is up 59% in the last year… and an incredible 409% in the last five years. The S&P 500 is up just 99% in the last five years.
Biotech stocks are doing so well for good reason. Some biotech companies are doing amazing things. In a recent edition of Extraordinary Technology, Chris Wood explained how a new biotechnology called “CAR T cell therapy” can effectively fight certain forms of cancer. (more)
No comments:
Post a Comment